(888) 552-6760 SCHEDULE AN APPOINTMENT

Stephen Gruber,

M.D., Ph.D., M.P.H.

Vice President, City of Hope National Medical Center, Medical Oncologist

Biography photo
Location
City of Hope Duarte
1500 East Duarte Road
Duarte, CA 91010
Specialties
Medical Oncology
Education
Medical school:
Board Certifications
  • 2008-2018, Diplomate, Recertified in Medical Oncology

  • 2004-2005, Visiting Scientist, Sabbatical, Institut Catala d’Oncologia, Barcelona, Spain

  • 1998-2008, Diplomate in Medical Oncology

  • 1995-2005, Diplomate in Internal Medicine

  • 1993, Diplomate of the National Board of Medical Examiners

Degrees
  • 1992, M.D., University of Pennsylvania, Philadelphia, PA

  • 1988, Ph.D., Epidemiology, Yale University, New Haven, CT

  • 1986, M.P.H., Graduate School, Yale University, New Haven, CT (Distinction)

  • 1984, B.A., English/Biology, University of Pennsylvania, Philadelphia, PA

Fellowship
  • 1994-1997, M.D., Medical Oncology, Johns Hopkins Hospital, Baltimore

Residency
  • 1997-1999, Clinical Medical Genetics, University of Michigan, Ann Arbor, MI

  • 1993-1994, Internal Medicine, University of Pennsylvania, Philadelphia, PA

Internship
  • 1992-1993, Internal Medicine, University of Pennsylvania, Philadelphia, PA

Professional Experience
  • 2019-present, Director, Center of Precision Medicine, and Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, California

  • 2011-2019, Professor, Preventive Medicine, University of Southern California, Los Angeles, CA

  • 2011-2019, Professor, Medicine, University of Southern California, Los Angeles, CA

  • 2011-2017, Director, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA

  • 2011-2012, Adjunct Professor, Internal Medicine, University of Michigan, Ann Arbor, MI

  • 2008-2011, Professor, Internal Medicine, Epidemiology, and Human Genetics, University of Michigan, Ann Arbor, MI

  • 2004-2008, Associate Professor, Internal Medicine, Epidemiology and Human Genetics (tenure), University of Michigan, Ann Arbor, MI

  • 2002-2004, Assistant Professor, Human Genetics, University of Michigan, Ann Arbor, MI

  • 1997-2004, Assistant Professor, Internal Medicine and Epidemiology, University of Michigan, Ann Arbor, MI

Academic Appointments
  • Eva and Ming Hsieh Family Director’s Chair of the Center for Precision Medicine
  • Professor, Division of Molecular Pharmacology, Department of Medical Oncology & Therapeutics Research
About Me

Stephen Gruber, M.D., Ph.D., M.P.H., is a doctor and researcher who is internationally known for his work in cancer genetics and precision medicine and the vice president of City of Hope® Cancer Center Duarte. Passionate about using the latest advances in science to create more personalized cancer care for patients and their families, Dr. Gruber is also an expert on Lynch syndrome and inherited forms of colorectal cancer. His approach to working with patients is to helps them understand their cancer risks and guide them through their options for both cancer prevention and treatment.

 At City of Hope, Dr. Gruber leads the Center for Precision Medicine, where doctors and scientists use a person’s unique genetic makeup to create the most accurate and effective care plans possible using the latest advances in oncology. His research focuses on how cancer is passed down in families, with a focus on cancers including melanoma and colorectal cancer. The goal of this work is to improve early detection rates and outcomes. 

Dr. Gruber earned his medical degree and completed his residency in internal medicine at the University of Pennsylvania in Philadelphia, before pursuing a fellowship in medical oncology at Johns Hopkins University in Baltimore, followed by a clinical medical genetics fellowship at the University of Michigan in Ann Arbor. He also holds a doctorate and master of public health from Yale University in New Haven, Connecticut. Dr. Gruber’s work has been funded since 1998 by the National Institutes of Health, making him a recognized leader in the field of cancer research.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.